全文获取类型
收费全文 | 7396篇 |
免费 | 361篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 219篇 |
妇产科学 | 161篇 |
基础医学 | 768篇 |
口腔科学 | 150篇 |
临床医学 | 492篇 |
内科学 | 1963篇 |
皮肤病学 | 133篇 |
神经病学 | 442篇 |
特种医学 | 409篇 |
外科学 | 1293篇 |
综合类 | 21篇 |
预防医学 | 244篇 |
眼科学 | 171篇 |
药学 | 360篇 |
中国医学 | 13篇 |
肿瘤学 | 936篇 |
出版年
2024年 | 10篇 |
2023年 | 92篇 |
2022年 | 139篇 |
2021年 | 266篇 |
2020年 | 161篇 |
2019年 | 230篇 |
2018年 | 287篇 |
2017年 | 182篇 |
2016年 | 216篇 |
2015年 | 222篇 |
2014年 | 349篇 |
2013年 | 401篇 |
2012年 | 566篇 |
2011年 | 585篇 |
2010年 | 327篇 |
2009年 | 295篇 |
2008年 | 470篇 |
2007年 | 446篇 |
2006年 | 397篇 |
2005年 | 451篇 |
2004年 | 384篇 |
2003年 | 354篇 |
2002年 | 309篇 |
2001年 | 62篇 |
2000年 | 47篇 |
1999年 | 52篇 |
1998年 | 75篇 |
1997年 | 54篇 |
1996年 | 46篇 |
1995年 | 46篇 |
1994年 | 37篇 |
1993年 | 27篇 |
1992年 | 28篇 |
1991年 | 20篇 |
1990年 | 26篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 13篇 |
1986年 | 23篇 |
1985年 | 12篇 |
1984年 | 14篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1977年 | 5篇 |
1975年 | 3篇 |
1973年 | 4篇 |
1971年 | 3篇 |
排序方式: 共有7824条查询结果,搜索用时 15 毫秒
71.
72.
Debora Soncini Claudia Martinuzzi Pamela Becherini Elisa Gelli Samantha Ruberti Katia Todoerti Luca Mastracci Paola Contini Antonia Cagnetta Antonella Laudisi Fabio Guolo Paola Minetto Maurizio Miglino Sara Aquino Riccardo Varaldo Daniele Reverberi Matteo Formica Mario Passalacqua Alessio Nencioni Antonino Neri Mehmet K. Samur Nikhil C. Munshi Mariateresa Fulciniti Roberto M. Lemoli Michele Cea. 《Haematologica》2022,107(6):1410
73.
Pessina A Raimondi A Croera C Acchini M Mineo E Foti P Neri MG 《Anti-cancer drugs》2001,12(5):441-451
In order to investigate the mechanisms of drug resistance arising in tumor cells, we investigated the capacity of fluoroquinolones to inhibit the in vitro growth of WEHI-3B monomyelocytic leukemia cells and then we established a variant of this line (currently maintained in the absence of drug). The line, named WEHI-3B/CPX, expresses a specific resistance to ciprofloxacin (CPX; resistance index=17.3+/-2.2), and does not show cross-resistance with other fluoroquinolones, camptothecin and topoisomerase II inhibitors such as doxorubicin, etoposide and teniposide. Although a little decrease in intracellular accumulation of CPX is observed in WEHI-3B/CPX cells, these cells do not express MDR or LRP markers, and the resistance is not circumvented by verapamil. Purified nuclear extracts from WEHI-3B and WEHI-3B/CPX cells were tested for topoisomerase I catalytic activity and checking in vitro topoisomerase I sensitivity to CPX and camptothecin inhibition, but no difference was observed. As the treatment with CPX showed that the resistant cell line suffers a significantly lower number of breaks in the DNA molecule we also addressed our investigations to the topoisomerase II-dependent DNA cleavage that, in the resistant clone, was found dramatically less susceptible to be enhanced by CPX both in pre-strand and post-strand DNA passage conditions. WEHI-3B/CPX cells do not express any character of multidrug resistance and represent a rare case of specific drug resistance to CPX. The specific resistance to CPX observed in these cells is related to a functional decrease of topoisomerase II cleavage activity. It could be consequent to a decreased binding affinity of CPX for the topoisomerase II--DNA complex or to a decreased affinity or specificity of topoisomerase II for its DNA cleavage sites. 相似文献
74.
Debora Franceschi Riccardo Di Gianfilippo Ida Rubino Lapo Serni Giovan Paolo Pini Prato 《Clinical Case Reports》2022,10(8)
Herpes Simplex Virus type 1 (HSV‐1) is a very common infection often localized in the mucocutaneous junction of the lip. Rarely, it could be detected also in periodontal tissues, associated with an elevated risk of periodontal disease progression and gingival recessions. Recently, HSV‐1 and numerous co‐infections have been reported in literature associated with the Coronavirus and subsequent COVID‐19 disease. This report illustrates a case of HSV‐1 in a patient with Covid‐19 infection, showing the presence of ulcers and vesicles on the gingival margin of maxillary teeth associated with soreness and pain. The histology highlighted the presence of intraepithelial cell ballooning, confirming the diagnosis of HSV‐1 infection. 相似文献
75.
76.
Bielska-Lasota M Inghelmann R van de Poll-Franse L Capocaccia R;EUROCARE Working Group 《Gynecologic oncology》2007,105(3):609-619
OBJECTIVE: To evaluate trends in survival from cervical cancer in Europe and in European countries participating in the EUROCARE study as a function of age, morphology and stage at diagnosis. METHODS: Relative survival and relative excess risk of death within 5 years of diagnosis, as a function of age, morphology and stage, among 73,022 women aged 15-99 years diagnosed during 1983-1994 and followed up to 1999 in each of 18 European countries participating in the EUROCARE study, using data from 34 population-based cancer registries. RESULTS: Overall five-year relative survival was 62%, rising by 2% during the period 1983-1994. The highest survival occurred in Northern and Western Europe and the lowest in Central Europe. Survival falls with age at diagnosis, but mainly for localised disease. Survival is higher for adenocarcinoma in younger women, but higher for squamous cell carcinoma in older women. The proportions of younger women, localised cancer and adenocarcinoma all increased. The main improvements in survival were for women under 65, and for metastatic disease. CONCLUSIONS: Survival in Europe has improved slowly but steadily, but the trend is not geographically uniform. Central European countries and the UK saw little or no improvement, and survival in those countries remains the lowest among participating countries in Europe. Further reduction of cervical cancer mortality in Europe may be expected from expansion of screening, and improvement in the treatment of older women, and of metastatic disease. 相似文献
77.
78.
Francesco Landi Riccardo Calvani Matteo Tosato Anna Maria Martone Domenico Fusco Alex Sisto Elena Ortolani Giulia Savera Sara Salini Emanuele Marzetti 《Journal of the American Medical Directors Association》2017,18(1):88.e17-88.e24
Objectives
Declining muscle mass and function are hallmarks of the aging process. The preservation of muscle trophism may protect against various negative health outcomes. Age- and sex-specific curves of muscle mass, strength, and function, using data from a large sample of community-dwelling people, are necessary.Material and methods
Two surveys (Longevity Check-up and Very Important Protein [VIP]), conducted during EXPO 2015 in Milan, consisted of a population assessment aimed at evaluating the prevalence of specific health metrics in subjects outside of a research setting (n = 3206), with a special focus on muscle mass, strength, and function. Muscle mass was estimated by using mid-arm muscle circumference (MAMC) and calf circumference of the dominant side. Muscle strength and function were assessed through handgrip strength testing and repeated chair stand test, respectively.Results
The mean age of 3206 participants in the Longevity Check-up and VIP surveys was 51.9 years (SD 15.6, range 18–98 years), and 1694 (52.8%) were women. Cross-sectional inspection suggests that both calf circumference and MAMC decline nonlinearly with age and the rate of decline varies by gender. These measures are stable until 50 years and then begin to decrease slightly with age, with the effect being more evident in men than in women. The main effect of the age category was observed in muscle strength and physical performance parameters. Muscle strength declined significantly after 45 years of age, both in men and women (P < .001). The muscle quality of the upper extremities, defined as handgrip strength divided by MAMC, declined significantly with aging, as well (P < .001). The time to complete the chair stand test was similar from 18 years to 40 to 44 years, and then a linear decline in performing the test across age groups was observed, with an increased time of more than 3 seconds, both in men and women (P < .001).Conclusions
Muscle mass and strength curves may be used to extract reference values for subsequent use in research as well as in the clinical setting. In particular, the analyses of trajectories of muscle parameters may help identify cutoffs for the estimation of risk of adverse events. 相似文献79.
80.
Brancatelli G Vilgrain V Federle MP Hakime A Lagalla R Iannaccone R Valla D 《AJR. American journal of roentgenology》2007,188(2):W168-W176
OBJECTIVE: The objective of our study was to illustrate the imaging findings of Budd-Chiari syndrome, including CT, MRI, sonographic, and angiographic findings. CONCLUSION: The key imaging findings in Budd-Chiari syndrome are occlusion of the hepatic veins, inferior vena cava, or both; caudate lobe enlargement; inhomogeneous liver enhancement; and the presence of intrahepatic collateral vessels and hypervascular nodules. Awareness of these findings is important for early diagnosis and appropriate treatment. 相似文献